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For centuries after its first description by Galen, the thymus was considered as only
a vestigial endocrine organ until the discovery in 1961 by Jacques FAP Miller of its
essential role in the development of T (thymo-dependent) lymphocytes. A unique thymus
first appeared in cartilaginous fishes some 500 million years ago, at the same time or
shortly after the emergence of the adaptive (acquired) immune system. The thymus may
be compared to a small brain or a computer highly specialized in the orchestration of
central immunological self-tolerance. This was a necessity for the survival of species,
given the potent evolutionary pressure imposed by the high risk of autotoxicity inherent
in the stochastic generation of the diversity of immune cell receptors that characterize
the adaptive immune response. A new paradigm of “neuroendocrine self-peptides” has
been proposed, together with the definition of “neuroendocrine self.” Neuroendocrine
self-peptides are secreted by thymic epithelial cells (TECs) not according to the classic
model of neuroendocrine signaling, but are processed for presentation by, or in association
with, the thymic major histocompatibility complex (MHC) proteins. The autoimmune
regulator (AIRE) gene/protein controls the transcription of neuroendocrine genes in TECs.
The presentation of self-peptides in the thymus is responsible for the clonal deletion of
self-reactive T cells, which emerge during the random recombination of gene segments
that encode variable parts of the T cell receptor for the antigen (TCR). At the same
time, self-antigen presentation in the thymus generates regulatory T (Treg) cells that
can inhibit, in the periphery, those self-reactive T cells that escaped negative selection in
the thymus. Several arguments indicate that the origin of autoimmunity directed against
neuroendocrine glands results primarily from a defect in the intrathymic programming of
self-tolerance to neuroendocrine functions. This defect may be genetic or acquired, for
example during an enteroviral infection. This novel knowledge of normal and pathologic
functions of the thymus constitutes a solid basis for the development of a novel type of
tolerogenic/negative self-vaccination against type 1 diabetes (T1D).
Keywords: thymus, self-tolerance, autoimmunity, type 1 diabetes, neuroendocrine self-peptides, oxytocin, insulin-
like growth factor 2, AIRE
INTRODUCTION
Galen (129–210 AC), who, with Hippocrates, is recognized as
one of the fathers of Western medicine, first observed, behind
the sternum and before the cardiac area, an organ that he named
“thymus” because of its resemblance to the leaf of the thyme plant
Thymus vulgaris. Galen also suspected that the thymus was the
seat of courage and affection because of its close vicinity to the
heart; in Ancient Greece, the word “thumos or thymos (θυμóς)”
indicated a physical association between breath and blood, and
referred to one of Plato’s three constituent parts of human psyche.
The function of the thymus remained unknown for many cen-
turies and it was considered only as a vestigial organ that had
become redundant both during phylogeny and ontogeny after
puberty. Then, at the beginning of the 20th century, Hammar
(Sweden) published a series of important studies describing
hyperplasia of the thymus in various endocrine diseases including
acromegaly and Graves’ disease, and after castration (Hammar,
1921). A few years later, Hans Selye reported that massive thymus
atrophy is observed soon after administration of glucocorticoids
(Selye, 1941), and this dramatic decrease in thymus size soon
became a hallmark of the general adaptation and stress syndrome.
At that time, the thymus was thought to be an endocrine gland
but, despite the identification of several thymic “hormones,” the
model of endocrine signaling failed to characterize the molecu-
lar dialogue between thymic epithelial cells (TECs) and immature
thymic T cells (thymocytes). The hypothesis that the thymus had
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an endocrine nature then progressively faded, afterMiller demon-
strated the immunological function of the thymus (Miller, 1961).
In this seminal paper, Miller postulated that lymphocytes leav-
ing the thymus are specially selected in an epithelial environment.
To the best of our knowledge, Burnet and Mackay published in
The Lancet the first hypothesis connecting autoimmune diseases
with histological abnormalities in the lympho-epithelial structure
of the thymus (Burnet and Mackay, 1963). Immunological toler-
ance was first shown to be induced by thymic epithelial grafts in
birds (Ohki et al., 1987), and the prominent role of the thymus in
the induction of central tolerance was established by investigating
the fate of developing thymocytes in response to superantigens
(Kappler et al., 1987) or in T cell receptor (TCR) transgenic mice
bearing a receptor for a HY-derived antigen (Kisielow et al., 1988).
The identification of thymus-derived regulatory T cells (tTreg)
(Sakagushi et al., 1995) completed our essential knowledge about
the physiological function of the thymus, i.e., the generation
of a diverse repertoire of TCRs that are self-tolerant and com-
petent against non-self. The central role of thymus-dependent
central self-tolerance has now become a cornerstone of immune
physiology (Mathis and Benoist, 2004; Kyewski and Klein, 2006).
THYMUS ORGANOGENESIS
Epithelial cells of the thymic cortex (cTECs, including thymic
“nurse” cells) andmedulla (mTECs) constitute around 85%of the
thymus parenchyme. Other cells of the thymic stroma—dendritic
cells (DCs) and macrophages—derive from the bone marrow.
TECs arise from the endoderm of the 3rd pharyngeal pouch that,
at around day 9 of embryonic development in the mouse (E9.0),
contains thymic common epithelial progenitors (Blackburn and
Manley, 2004; Anderson et al., 2007). Further development of this
primitive epithelial rudiment between E9.5 and E12.5 depends on
mesenchyme derived from the cephalic neural crest, the role of
which extends beyond the early stages of thymus organogenesis
(Foster et al., 2008).
Some human diseases and animal models involve a defect
in thymus development, which leads to primary immune defi-
ciencies. Di George’s syndrome associates congenital absence or
hypoplasia of the thymus and parathyroid glands together with
defects in the heart and truncal vessels. This syndrome results
partly from a migration failure of the cephalic neural crest. More
recently, transgenic mouse models have revealed some of the
molecular mechanisms involved in thymus development. Thus,
Hoxa3−/− mice present thymic aplasia, parathyroid hypopla-
sia, that are often accompanied by defects of the heart and
the great truncal vessels (Manley and Capecchi, 1995). In mice,
the “nude” phenotype results from mutations in the nude gene
locus on chromosome 11 that encodes the transcription factor
winged-helix nude (whn) or forkhead box N1 (Foxn1) (Nehls
et al., 1994). Foxn1 is a master regulator gene of the TEC dif-
ferentiation programme; it controls lineage progression in cTECs
and mTECs, and regulates a series of genes implicated in TEC
function, although is not essential for medullary sublineage diver-
gence (Nowell et al., 2011). Importantly, the genetic mechanisms
responsible for murine thymus organogenesis are conserved in
humans (Farley et al., 2013) and this is important with regard
to current attempts to regenerate the thymus in aging, as well as
in many other clinical conditions associated with compromised
immune function (Holländer et al., 2010). Indeed, contrary to
earlier dogma, the thymus is functional until an advanced age,
and thymopoiesis plays a central role in immune reconstitution
after intensive chemotherapy or anti-retroviral treatment (Douek
et al., 1998).
OVERVIEW OF T CELL DIFFERENTIATION IN THE THYMUS
The T cell immune system may be regarded as a 6th sensory
organ that responds to different kinds of danger signals that are
not detected by nerve cells. From the fetal liver, and later from
the bone marrow, T lymphocyte progenitors migrate through the
boundary between cortex and medulla into the thymic epithe-
lial rudiment in response to chemoattractant factors (Wilkinson
et al., 1999). They undergo many mitotic divisions in the outer
cortex, and then differentiate after presentation of peptides by
major histocompatibility complex (MHC) proteins expressed by
thymic antigen-presenting cells (essentially cTECs, mTECs, DCs,
and macrophages). The stochastic rearrangement of related β–
then α-chains generates an enormous diversity of TCRs, many of
which can bind self-antigen/MHC complexes with high affinity
and are subsequently deleted (negative selection). Clonal deletion
of thymocytes can occur both in the cortex and in the medulla
(McCaughtry et al., 2008), but is most effective in the medulla.
Self-antigen presentation by thymicMHC proteins determines
the whole process of T cell differentiation, which includes three
alternative and exclusive fates for developing thymocytes: (1)
Negative selection of self-reactive T cells generated during the
random generation of TCR diversity due to the activity of the
two recombination-activating enzymes RAG-1 and RAG-2; (2)
Generation of self-specific tTreg cells; and (3) Positive selection
of CD4+ and CD8+ effector and self-tolerant T cells. The first
two events establish the establishment of the central arm of self-
tolerance, while the avidity-affinity of the TCR—self-antigen—
MHC interaction determines T cell negative or positive selection
(Ashton-Rickardt et al., 1994). A remaining question is how the
same MHC—self-peptide complexes can mediate either negative
selection of self-reactive T cells or generation of self-specific tTreg
cells (Klein et al., 2009; Stritesky et al., 2012). Another crucial
question concerns the precise biochemical nature of self-peptides
that are presented in the thymus, in particular during fetal life.
NEUROHYPOPHYSIAL FAMILY-RELATED PEPTIDES AND
RECEPTORS IN THE THYMUS NETWORK
At the beginning of the 20th century, English scientists reported
the galactogogue activity of thymus and corpus luteum extracts
after their injection into the goat (Ott and Scott, 1910). At that
time, oxytocin (OT) had not yet been identified as the specific fac-
tor of galactokinesis, which would be established in the late 50’s
by Vincent du Vigneaud and his team. In 1986, human thymus
extracts were shown to possess potent uterine oxytocic activity,
and OT was identified as the dominant member of the neuro-
hypophysial family synthesized by TECs and thymic nurse cells
in humans and different animal species (Geenen et al., 1986).
Thymic T cells also express the OT receptor (OTR) and the V1b
(or V3) vasopressin (AVP) receptor, which transduce nanomolar
concentrations of OT and, accordingly to the rules of signaling
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induced by OTR and V1b, these receptors transduce low con-
centrations of OT and AVP via the phosphoinositide pathway
in mitogenic signals for freshly isolated thymocytes (reviewed in
Martens et al., 1996a,b). Together, these data showed the exis-
tence of a functional signaling within the thymus mediated by
OT synthesized by TECs acting on functional OTR and V1b
receptors expressed by developing T cells. Furthermolecular char-
acterization of the neurohypophysial receptors present in the
murine thymus showed that Otr is transcribed by all thymic
T cell subsets, while V1b is expressed only in double positive
CD4+8+ and single positive CD8+ T cells (Hansenne et al.,
2005). Because intrathymic OT concentrations are in agreement
with the high affinity Kd (10−9–10−10 M) of neurohypophysial
receptors expressed by pre-T cells, the physico-chemical condi-
tions are conducive to a functional signaling within the thymus
network, which is not the case for the blood-borne OT and AVP,
due to their low plasma concentration (10−11–10−12 M).
Despite the strong evidence for the presence of neurohy-
pophysial ligands and receptors in the thymus network, no secre-
tion of OT or neurophysin could be detected in primary cultures
of freshly isolated human TECs. Moreover, in the murine thy-
mus, OT is not located in secretory granules but is diffuse in
cytosol, in vesicles of the endoplasmic reticulum, and associated
with keratin filaments (Wiemann and Ehret, 1993). This posed
a fundamental problem, since the neuropeptide OT had been
the basis for the development of the neurosecretion model by
the Sharrer’s in the 40′s. However, in 1990, Funder proposed
a model of cell-to-cell cryptocrine (hidden secretion) signaling
to characterize the direct membrane-to-membrane exchange of
information between large epithelial nursing cells (like TECs in
the thymus and Sertoli cells in the testis) and immature ele-
ments that migrate and differentiate at their contact (respectively,
thymocytes and spermatocytes).
We thus proposed that, in the thymus, OT mediates a cryp-
tocrine signaling between TECs and pre-T cells (Geenen et al.,
1991). The observation of numerous points of focal adhesion
between OT+ TECs and immature T cells (Wiemann and Ehret,
1993) prompted us to investigate the hypothesis that thymic OT
could stimulate the activation of focal adhesion kinases (FAKs)
in thymocytes. Among the proteins phosphorylated by OT in
murine pre-T cells, two were precipitated with an anti-FAK mAb:
one was identified as the p125FAK, while the other was a copre-
cipitating 130-kD protein (most probably p130Cas). In pre-T
cells, OT also phosphorylates paxillin, a 68-kD protein located at
focal adhesion sites and associated with p125FAK (Martens et al.,
1998). Together, these data establish the existence of a functional
OT-mediated cryptocrine signaling in the thymus network. The
OT-mediated promotion of focal adhesion may contribute to the
establishment of immunological “synapses” between TECs and
immature T cells, which is fundamental for the completion of the
T cell differentiation programme.
A PARADIGM SHIFT: FROM THYMIC NEUROPEPTIDES TO
“NEUROENDOCRINE SELF-PEPTIDES”
As discussed above, self-antigen presentation by thymic MHC
proteins is the essential mechanism that determines the whole
process of T cell differentiation. Because OT and its associated
neurophysin are self-peptides synthesized in TECs, we hypoth-
esized a processing of the thymic OT precursor that would be
related to antigen presentation rather than classical neurosecre-
tion. If true, such a processing would fit with the model of
cryptocrine signaling, which implicates a membrane targeting
of the ligand. Following affinity-chromatography with a mAb
against the monomorphic part of human MHC class I molecules,
we identified, in human TEC plasma membrane, a 55-kD protein
that was labeled by both anti-MHC class I mAb and a spe-
cific anti-neurophysin antiserum. Because this antiserum does
not cross-react either with MHC class I proteins, or with β2-
microglobulin, this 55-kD membrane protein could represent
a hybrid protein including a neurophysin domain (10 kD) and
a MHC class I heavy chain-related domain (45 kD). The for-
mation of this hybrid could reside at the post-transcriptional
level (such as a trans-splicing event) or at the post-translational
level (such as ATP-dependent ubiquitinylation). The MHC class
I domain could be implicated in the membrane targeting of
the hybrid, whereas the neurophysin domain would bind OT
for final presentation to pre-T cells. According to this expla-
nation, the neurophysin part of the OT precursor could fulfill
the same function in the thymus and in the hypothalamo-
neurohypophysial axis: binding of the peptide OT and trans-
port to the external limit of TECs or magnocellular neurons,
respectively. The tyrosine residue in position 2 of OT plays an
important role in its binding to neurophysin (Griffin et al.,
1973) and, interestingly, the tyrosine residue in the same posi-
tion plays a crucial role in the binding of antigens to some
MHC class I alleles for their presentation (Maryanski et al.,
1991).
The antigenic behavior of thymic OT is also supported by
another type of experiment. The recognition of OT by specific
mAbs at the outer surface of TEC plasma membrane induces
a marked increase in the secretion of interleukin 6 (IL-6) and
leukemia inhibitory factor (LIF) in the supernatant of human
TEC primary cultures (Martens et al., 1996a,b). Given the nature
of the specific epitopes recognized by anti-OT mAbs, it was con-
cluded that OT is fully processed at the level of the TEC plasma
membrane. The absence of any effect of anti-AVP mAbs fur-
ther supports the conclusion that thymic OT behaves as the
self-peptide of the neurohypophysial family.
Because OT is a cyclic nonapeptide, and since antigen pre-
sentation mostly concerns linear sequences, the hypothesis of a
similar processing was investigated with the linear neurotensin
(NT). Primary cultures of human TECs contain around 5 ng of
NT/106 cells, of which 5% is associated with TEC plasma mem-
branes. Again, no NT was detected in the supernatant of human
TEC cultures. High performance liquid chromatography analy-
sis of NT present in human TEC revealed a major peak of NT
corresponding to intact NT1−13. Using the same affinity column
prepared with an anti-MHC class I mAb, NT, and NT-related
peptides were retained on the column and were eluted together
with MHC class I proteins (Vanneste et al., 1997). The C-terminal
sequence of NT includes tyrosine, isoleucine, and leucine residues
that all can be used to anchor most of MHC class I alleles.
Thus, NT and NT-derived C-terminal fragments could be natural
ligands for MHC class I alleles.
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At this point and in association with the characterization of
the thymic peptides related to different neuroendocrine fami-
lies (Geenen et al., 1998), the biochemical nature and properties
of the “neuroendocrine self” could be defined according to the
following features:
1. Neuroendocrine self-peptides are the dominant members of
neuroendocrine gene/protein families that are expressed in
TECs of many species and usually correspond to sequences
that have been highly conserved during the evolution of a given
family.
2. A hierarchy characterizes their expression profile. In the neu-
rohypophysial family, OT is the dominant peptide expressed
in TECs from different species. In the tachykinin family, neu-
rokinin A (NKA)—but not substance P—is the peptide gen-
erated from the processing in TECs of the preprotachykinin A
gene product (Ericsson et al., 1990). In the insulin family, all
members are expressed in the thymus network: IGF-2 (cTECs
andmTECs)> IGF-1 (cTECs, mTECs, andmacrophages)>>
Insulin (rare subsets of mTECs). This hierarchical pattern is
important, because the strength of immunological tolerance
to a protein/peptide is proportional to its concentration in the
thymus (Ashton-Rickardt et al., 1994). Blocking thymic IGF-
mediated signaling at the level of IGF ligands (in particular
IGF-2) or IGF receptors interferes with the early stages of T
cell differentiation, while one mAb to proinsulin did not exert
any significant effect (Kecha et al., 2000).
3. The autoimmune regulator gene/protein (AIRE) controls the
degree of intrathymic transcription of the genes encoding
neuroendocrine self-peptides (Anderson et al., 2002).
4. In the thymus, neuroendocrine precursors are not pro-
cessed according to the model of neurosecretion but undergo
antigenic processing for presentation by—or in association
with—MHC proteins. This processing differs between thymic
antigen-presenting cells (APCs) and professional APCs (DCs,
B cells, andmacrophages) in the periphery. For some neuroen-
docrine self-peptides (OT and NT), such differences imply
that their presentation in the thymus is not tightly restricted
by MHC alleles as much as presentation of nonself antigens
and autoantigens by dedicated APCs in the periphery.
5. For some precursors of neuroendocrine self-peptide pre-
cursors, their transcription in TECs precedes their ortho-
topic expression in peripheral neuroendocrine glands/cells
(Hansenne et al., 2005).
Therefore, depending on their behavior either as the source of
neuroendocrine self-peptides or cryptocrine signals, the thymic
repertoire of neuroendocrine precursors recapitulates at the
molecular level the dual role of the thymus in T cell negative and
positive selection.
INTEGRATED COEVOLUTION OF THE NEUROENDOCRINE
AND IMMUNE SYSTEMS (FIGURE 1)
Throughout evolution, the neuroendocrine and innate immune
systems have evolved in parallel, and coexist in all animal species
without any apparent aggression of the innate immune system
toward neuroendocrine glands. Indeed, Toll-like receptors, which
are the essential mediators of innate response, do not react against
normal or undamaged self. Some anticipatory immune responses
are present even in jawless vertebrates (agnathans), mediated by
FIGURE 1 | Integrated evolution of the immune and neuroendocrine
systems. Neuroendocrine principles are evolutionarily ancient and did not
evolve extensively except by gene duplication and differential RNA splicing.
A high risk of inherent autoimmunity toward the neuroendocrine tissues
resulted from the appearance of RAG-dependent adaptive immunity in jawed
cartilaginous fishes. Preceded by ancestor thymoids in lamprey larvae, the
first unique thymus emerged in jawed vertebrates, and the intrathymic
presentation of neuroendocrine self-peptides (arrows) may be viewed a
posteriori as a very efficient and economical way to instruct the adaptive
T cell system in tolerating neuroendocrine functions as early as during
thymus-dependent cell differentiation. VCBP, variable region-containing
chitin-binding protein; VLR, variable lymphocyte receptor.
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diverse variable lymphocyte receptors (VLRs), with 4–12 leucine-
rich repeat modules assembled by some gene conversion process.
Some 500 million years ago, the emergence of transposon-like
genes coding for recombination-activating enzymes RAG-1 and
RAG-2 in cartilaginous fishes (sharks and rays, mainly) initi-
ated the development of adaptive immunity (Agrawal et al., 1998;
Boehm and Bleul, 2007; Hirano et al., 2011). The appearance of
these two genes in the genome of gnathostomes (probably via hor-
izontal transmission), and the subsequent appearance of the com-
binatorial immune system has been sometimes described as the
“Big Bang” of immunology. Gene recombination in somatic lym-
phoid cells is responsible for the stochastic generation of diverse
immune receptors for antigen, B-cell receptors (BCRs,±5 × 1013
combinations) and T-cell receptors (TCRs,±1018 combinations).
This extreme diversity of antigen receptors was directly asso-
ciated with a high inherent risk of autoxicity that threatened
survival of both species and individuals. This evolutionary pres-
sure was so strong that, in accordance with Paul Ehrlich’s concept
of horror autotoxicus, novel structures, and mechanisms appeared
with the specific role of protecting self against potential autoim-
mune attacks and orchestrating immunological self-tolerance.
The first unique thymus also appeared in jawed cartilaginous
fishes, concomitantly or very shortly after the emergence of adap-
tive immunity. The thymus did not abruptly appear but, as
elegantly demonstrated by Bajoghli et al. (2011), was preceded
by thymus-like lymphoepithelial structures in the gill baskets of
lamprey larvae. These “thymoids” express the gene encoding fork-
head box N4 (Foxn4), the ortholog of Foxn1, the transcription
factor responsible for the differentiation of TECs in higher ver-
tebrates as discussed above. Foxn1 thus stands at a crucial place
in the emergence of thymus epithelium that is essential for the
control of T cell differentiation and self-tolerance programming
(Boehm, 2011). The same study also provided strong evidence
for a functional analogy between VLR assembly in thymoids and
TCR recombination in the thymus, opening the hypothesis of
autoimmune-like phenomena in jawless vertebrates.
The hierarchic organization of the thymic repertoire of neu-
roendocrine self-peptides is also very significant from an evo-
lutionary point of view. Because major neuroendocrine prin-
ciples had been established before the emergence of the antic-
ipatory adaptive immune response, they had to be protected
from the risk of autoimmunity inherent to this immune lot-
tery. OT is a hypothalamic nonapeptide that is closely impli-
cated at different steps of the reproductive process, from social
affiliation and bonding to control of parturition and lacta-
tion. Thus, OT is fundamental for the preservation of ani-
mal and human species. Through its dominant expression in
TECs, OT is much more tolerated than AVP, its hypothalamo-
neurohypohysial homolog, which mainly controls water home-
ostasis and vascular tone. Interestingly, rare cases of autoim-
mune hypothalamitis with AVP deficiency and diabetes insipidus
have been repeatedly observed (de Bellis et al., 2004), but no
autoimmunity against OT has ever been reported. Similarly in
the insulin family, insulin is the primary autoantigen of type
1 diabetes (T1D) while there is no report of autoimmunity
against IGF-2, a growth factor fundamental for fetus develop-
ment and individual ontogeny. However, because of their close
homology, however, thymic neuroendocrine self-peptides pro-
mote immunological cross-tolerance to their whole family, and
tolerance to insulin is indeed lower in Igf2−/− than in wild-
type mice (Hansenne et al., 2006). Despite IGF-2 ubiquitous
expression in extrathymic tissues, the deletion of Igf2 in murine
Foxn1+ TECs is also associated with a significant decrease in
immunological tolerance to IGF-2 and to insulin (unpublished
observations).
A DEFECT OF CENTRAL SELF-TOLERANCE AS THE PRIMARY
EVENT DRIVING DEVELOPMENT OF AUTOIMMUNITY
(FIGURE 2)
The evidence that T cells are programmed to recognize and tol-
erate the whole insulin family during their differentiation in the
thymus prompted us to investigate the hypothesis of a defect in
this education process as a potential source of self-reactive T cells
directed specifically against insulin-secreting β cells of the pan-
creas. In other words, instead of considering autoimmune T1D
as pathology of the pancreas, should we now consider the thy-
mus as the primary defective organ? Already in 1973, Burnet
theorized that the pathogenesis of autoimmune diseases first
depends on a failure of self-tolerance and the appearance of “for-
bidden” self-reactive immune clones in the peripheral repertoire
(Burnet, 1973), and even before the development of transgenic
mice, a number of studies had provided elegant data supporting
this hypothesis. Neonatal thymectomy prevents the emergence
of autoimmune diabetes in an animal model of human T1D,
the bio-breeding (BB) rat (Like et al., 1982). This benefit of
neonatal thymectomy may now be explained by the removal of
a defective thymus responsible for the continuous release and
peripheral enrichment of the peripheral T cell repertoire with
“forbidden” intolerant self-reactive T cells. Conversely, transplan-
tation of thymus from diabetes-resistant (BBDR) to diabetes-
prone BB (BBDR) rats prevents autoimmune diabetes in the
latter (Georgiou and Bellgrau, 1989). Grafts of pure TECs from
NOD mouse embryos to newborn C57BL/6 athymic nude mice
also induce CD4 and CD8 T cell-mediated insulitis and sialitis
(Thomas-Vaslin et al., 1997). Central tolerance and intrathymic
apoptosis of self-reactive T cells were suspected to be defective
in the NOD thymus (Kishimoto and Sprent, 2001; Zucchelli
et al., 2005). However, a very careful recent study has estab-
lished that thymic negative selection is functional in NOD mice
(Mingueneau et al., 2012).
Transcription of all insulin-related genes has been investi-
gated in the thymus of BBDR and BBDP rats. Ins and Igf1
transcripts were detected in all BBDP and BBDR thymi whereas
Igf2 transcripts were also detected in all BBDR thymi but in
only in 4 of 15 BBDP thymi. Such a defect of Igf2 transcrip-
tion in BBDP thymus could contribute both to their lym-
phopenia (including CD8+ T and RT6+ Treg cells) and to the
absence of central tolerance to islet β cells (Kecha-Kamoun et al.,
2001). In humans, INS transcripts are measured at a lower level
in the thymus from fetuses with short class I variable num-
ber of tandem repeat (VNTR) alleles, the second genetic trait
(IDDM2) of T1D susceptibility (Pugliese et al., 1997; Vafiadis
et al., 1997). A number of other genetic loci associated with sus-
ceptibility to T1D could certainly determine disturbances in the
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FIGURE 2 | Physiology of the thymus and the primary role of a thymus
dysfunction in the development of autoimmune endocrine diseases.
Throughout life, the thymus generates naïve T cells that are self-tolerant and
competent against nonself-antigens, as well as self-specific
thymus-dependent regulatory T (tTreg) cells. Under AIRE control, thymus
epithelium (and mTECs particularly) transcribes genes encoding
neuroendocrine self-peptides, as well as other tissue-restricted antigens. The
absence or decrease in the intrathymic presentation of neuroendocrine
self-peptides conducts to a continuous enrichment of the peripheral T cell
repertoire with “forbidden” self-reactive T cells (Teff) bearing a TCR directed
against neuroendocrine self-antigens, while thymic generation of specific
tTreg cells is severely impaired. This thymus defect results in the absence of
central self-tolerance to neuroendocrine tissues/cells, which is a condition
necessary but not sufficient to initiate an autoimmune endocrine disease.
Environmental factors also intervene in the promotion of a molecular bridge
between self-reactive Teff and target neuroendocrine antigens.
thymus-dependent programming of central self-tolerance toward
islet β cells.
In mice, where two genes code for (pro)insulin (Ins1 and Ins2),
Ins2 is predominantly transcribed in rare subsets of mTECs while
Ins1 is dominantly expressed in murine islet β cells, which leads
to a higher immunological tolerance to Ins2. This difference in
the topography of Ins2 and Ins1 expression explains why breeding
of Ins2−/− mice onto the NOD background markedly acceler-
ates insulitis and diabetes onset (Thebault-Baumont et al., 2003),
while the incidence of insulitis and autoimmune diabetes is con-
siderably reduced in Ins1−/− congenic NOD mice (Moriyama
et al., 2003). Susceptibility to autoimmune diabetes is also cor-
related with the level of Ins2 transcription in the murine thymus
(Chentoufi and Polychronakos, 2002). The role of thymic insulin
in mediating central tolerance to islet β cells was demonstrated
by the very rapid onset of autoimmune diabetes after a thymus-
specific Ins1 and Ins2 deletion resulting from the crossing of
Ins1−/− mice with others presenting a specific Ins2 deletion in
Aire-expressing mTECs (Fan et al., 2009). Of note, Ins2 tran-
scription in mTEC clones is not regulated by glucose (Levi and
Polychronakos, 2009) and is increased about 20-fold by anti-
lymphotoxin β mAb (Palumbo et al., 2006). Ins transcription
in mTECs uses a start site different than in pancreatic islet β
cells (Villasenor et al., 2008). In addition to Aire, the insulin
transactivator MafA also induces Ins transcription in the thymus;
targeted Mafa disruption reduces Ins2 expression in the thymus
and induces anti-islet autoantibodies (Noso et al., 2010).
The identification of the autoimmune regulator (AIRE)
gene, a member of the zinc-finger gene family, led to an
extremely important advancement in our knowledge of the cen-
tral role played by a thymus dysfunction in the pathogenesis
of organ-specific autoimmune diseases (The Finnish-German
APECED Consortium, 1997). AIRE mutations are responsible
for a rare recessive congenital syndrome called autoimmune
polyglandular syndrome type 1 (APS-1) or Autoimmune Poly-
Endocrinopathy, Candidiasis, Ectodermal Dystrophy (APECED)
syndrome. AIRE encodes a protein with structural characteristics
of a transcription factor: its transcription is maximal in thy-
mus epithelium, and Aire−/− mice develop several autoimmune
processes associated with a marked decrease in the intrathymic
expression of numerous neuroendocrine self-peptides (Anderson
et al., 2002). It also appears that both VNTR alleles (IDDM2)
and the level of AIRE transcription in the thymus determine
the concentration of INS transcripts in the human thymus
(Sabater et al., 2005). The two plant homeodomains (PHDs)
are critical regions for Aire function (Peterson et al., 2008);
PHD2 strongly influences the ability of Aire to control the
mTEC transcriptome and is therefore crucial for effective cen-
tral tolerance induction (Yang et al., 2013). RANK signals
from CD4+CD3− lymphoid tissue inducer (LTi) cells regulate
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the development and differentiation of Aire-expressing mTECs
(Rossi et al., 2007). Very recently, a mutual interdependence
between Aire and microRNAs (miRs) was evidenced in the thy-
mus since the profile of miR expression is severely affected in
isolated murine and human mTECs from Aire−/− mice and
since, in turn, Aire expression is downregulated in mTECs
of Dicer null mutant mice (Macedo et al., 2012; Ucar et al.,
2013).
An additional level of protection against autoimmunity is
also provided by peripheral mechanisms of immunological toler-
ance that inactivate self-reactive T lymphocytes that have escaped
the thymic censorship. Interestingly, extrathymic Aire-expressing
cells were very recently identified as distinct bonemarrow-derived
tolerogenic cells that anergize effector self-reactive CD4+ T cells
in secondary lymphoid organs (Gardner et al., 2008, 2013). These
data further demonstrate that the Aire gene/protein is an essential
shield against autoimmunity (Metzger and Anderson, 2011).
For several years, we have been investigating a novel hypoth-
esis according which an infection by the enterovirus Coxsackie
B4 (CVB4) could induce a thymus dysfunction and an impair-
ment of central tolerance to the insulin protein/gene family. CVB4
can directly infect the epithelial and lymphoid compartments of
the human and murine thymus, and promote a severe thymus
dysfunction with massive pre-T cell depletion and a marked-up
regulation of MHC class I expression by TECs and by double pos-
itive CD4+CD8+ immature thymic T cells (Brilot et al., 2002,
2004). CVB4 infection of murine fetal thymic organ cultures also
interferes with T cell differentiation (Brilot et al., 2008). Outbred
mice can be infected with CVB4 following oral inoculation, which
results in systemic spreading of viral RNA and a prolonged detec-
tion of CVB4 RNA in thymus, spleen, and blood up to 70 days
after inoculation (Jaïdane et al., 2006). Moreover, CVB4 infection
of amurinemTEC line induces a dramatic decrease in Igf2mRNA
and IGF-2 protein in this cell line, while Igf1 transcripts were
relatively unaffected. In this mTEC line, Ins2 transcripts could
not be detected (Jaïdane et al., 2012). Together, our data strongly
suggest that CVB4 infection of the thymus could disrupt central
self-tolerance to the insulin family, and could also enhance CVB4
virulence through induction of central tolerance to this virus.
With regard to autoimmune thyroiditis, which is the most fre-
quent autoimmune endocrine disease, all major thyroid-specific
antigens, i.e., thyroperoxydase, thyroglobulin, and thyrotropin
receptor (TSHR), are also transcribed in human TECs in nor-
mal conditions (Paschke and Geenen, 1995; Sospedra et al., 1998).
As first reported by Hammar, thymic hyperplasia is commonly
observed in Graves’ disease (Murakami et al., 1996), and homozy-
gotes for an SNP allele predisposing to Graves’ disease have
significantly lower intrathymic TSHR transcripts than carriers of
the protective allele (Colobran et al., 2011).
With regard to autoimmunity directed against peripheral
nonendocrine organs, a defect in α-myosin expression in TECs
was recently shown to exert a central role in the pathogenesis of
autoimmune myocarditis in mice and humans (Lv et al., 2011; Lv
and Lipes, 2012). Also, a defect in Aire-mediated central tolerance
to myelin protein zero promotes the development of an autoim-
mune Th1 effector response toward peripheral nerves (Su et al.,
2012).
THE CONCEPT OF “NEGATIVE/TOLEROGENIC
SELF-VACCINATION”
Although Ins2 is expressed at low levels in rare mTECs, thymic
(pro)insulin has an essential role in protecting islet β cells against
diabetogenic autoimmunity. However, insulin per se does not
exert any significant tolerogenic properties that could be exploited
to reprogram immunological tolerance to islet β cells. With the
exception of two studies (Fourlanos et al., 2011; Roep et al., 2013),
all the clinical trials based on insulin administration by different
ways failed to preserve the residual β cell mass once the autoim-
mune attack has induced patent T1D. On the contrary, the potent
immunogenic properties of insulin were revealed in different
studies (Blanas et al., 1996; Liu et al., 2002), and this immuno-
genicity could be related to the very low level of insulin gene
transcription in the thymus. Other studies have also evidenced the
risk of hypersensitivity or anaphylaxis following administration
of an autoantigen (Pedotti et al., 2001).
Nevertheless, the development of peptide-based therapeutic
vaccines remains an attractive approach because of the speci-
ficity of immune suppression or regulation directed to specific
pathogenic self-reactive T cells. In this context, infusion of a
strongly active insulin mimetope was recently shown to convert
naïve T cells into Foxp3+ Treg cells in vivo and to prevent autoim-
mune diabetes in NOD mice (Daniel et al., 2011). We proposed
that IGF-2 could be a safer and more valuable basis for develop-
ing a specific “negative/tolerogenic self-vaccination,” on the basis
that Igf2 transcription is defective in the thymus of BBDP rats
(Kecha-Kamoun et al., 2001) and that IGF-2 mediates significant
cross-tolerance to insulin (Hansenne et al., 2006). The concept of
negative self-vaccination implies both the competition between
IGF-2 and insulin-derived epitopes for presentation by DQ2
and DQ8 alleles, as well as a tolerogenic response—including
recruitment of Treg cells–induced byMHC-presentation of IGF-2
self-peptides (Geenen et al., 2004, 2010).
CONCLUSION
Our studies have established that the thymus is not a classical
neuroendocrine gland, but an obligatory intersection between
the adaptive immune and neuroendocrine systems (Geenen,
2010). Moreover, they have elucidated how thymic epithelium is
responsible for the programming of immunological central self-
tolerance toward neuroendocrine functions through presentation
of neuroendocrine self-peptides. They have also helped to resolve
three major questions concerning the pathogenesis of autoim-
mune endocrine disorders:Why are the neuroendocrine glands so
frequently tackled by an autoimmune process? What is the origin
of the pathogenic effector self-reactive T cells? And what explains
the tissue/cell-specificity of the autoimmune processes? There is
no doubt that this novel knowledge will soon be exploited for
the development of innovative strategies to prevent and cure a
variety of organ-specific devastating autoimmune diseases such
as T1D.
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